During the past decade, Klinische Forschung Schwerin conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinische Forschung Schwerin" #1 collaborator was "Biofortis Mérieux NutriSciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Klinische Forschung Schwerin" are "Diabetes type2" (1 trials), "Dysglycemia" (1 trials), "Osteoarthritis" (1 trials) and "Prediabetic State" (1 trials). Many other conditions were trialed in "Klinische Forschung Schwerin" in a lesser frequency.

Most popular intervention types in "Klinische Forschung Schwerin" are "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Placebo 3 intakes per day" (1 trials), "SD-6010" (1 trials), "TOTUM-63 2 intakes per day" (1 trials) and "TOTUM-63 3 intakes per day" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinische Forschung Schwerin" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinische Forschung Schwerin". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinische Forschung Schwerin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinische Forschung Schwerin, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".